Safety signals
Adverse-event patterns and emerging risks detected across sites and visits — surfaced early, ranked by relevance.
Flagged and prioritised for your reviewers — not auto-actioned.
AI Clinical Monitoring
AI-Powered Clinical
Surface important trial signals faster
AI-Powered Clinical
Trial Monitoring
See how Leggy Labs helps clinical-trial teams identify and prioritise safety, protocol and data-quality signals — while qualified humans remain in control.
Machines surface the signal — qualified humans keep control.
See it in action
This is what you're actually buying.
One flagged signal, from detection to human decision — on synthetic trial data.
High priority
Participant P-0042
Why flaggedPredefined monitoring criteria triggered.
AI actionRoute to qualified human reviewer.
Clinical decisionNone made by AI.
Awaiting reviewer decision — no action taken automatically.
What we surface
Three signal families. One human in control.
Leggy Labs continuously reads your trial data and separates noise from what matters — then hands the prioritised shortlist to the people who decide.
Protocol signals
Deviations and eligibility or visit-window breaches identified against your protocol logic.
Flagged and prioritised for your reviewers — not auto-actioned.
Data-quality signals
Missing, inconsistent or outlier data caught before it distorts the picture at lock.
Flagged and prioritised for your reviewers — not auto-actioned.
How it reaches your team
Ranked, routed, and waiting for a human call.
Every detected signal lands in a prioritised review queue — scored by severity and confidence, tagged by family, and assigned to the right reviewer. Nothing is auto-actioned. The queue below is illustrative, built on synthetic data.
- High priority — surfaced first for immediate reviewer attention.
- Medium — queued with context for scheduled review.
- Low / informational — logged, monitored, escalated if it trends.
1
Safety · AE cluster
High
2
Protocol · Visit-window breach
Medium
3
Data quality · Outlier value
Low
Awaiting reviewer decision — no action taken automatically.
The model narrows the field. A qualified human makes the call. Every time.
Trusted by clinical teams
Reviewers who own the decision, backed by the signal.
Meridian Bio
Aldera Therapeutics
Northvale CRO
Corran Clinical
“What changed for us wasn't automation — it was getting the right five signals to the top of the queue instead of drowning in a thousand. My monitors spend their time deciding, not searching.”
DR
Dr. Helena Reyes
Clinical Operations Director, Meridian Bio
Clinical Operations Director, Meridian Bio
“The human-in-the-loop framing is why our governance team took it seriously. Nothing is auto-actioned — the platform surfaces, our reviewers decide.”
TA
Tomas Andersen
Head of Data Management, Northvale CRO
Head of Data Management, Northvale CRO
Book a demo
Request a Leggy Labs Demo
Tell us about your organisation and clinical-trial requirements. Our team will contact you to arrange a demonstration.
- Walkthrough tailored to your therapeutic area and trial phase.
- See how signals are ranked, routed and reviewed by your team.
- No obligation — a conversation, not a contract.
Who we work with
Built for Clinical Trial Teams
Leggy Labs is shaped around the workflows of the people who run trials — the reviewers, monitors and data leads who own every decision the platform supports.
Biotech companies
CROs
Clinical Operations teams
Clinical Data Management teams
Clinical Development teams
Honest disclosure
Leggy Labs is currently demonstrated using synthetic clinical-trial data. The platform is not a medical diagnostic or treatment system. Clinical deployment requires appropriate validation, security, governance and regulatory assessment.